|
1
|
Khoury JD, Solary E, Abla O, Akkari Y,
Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, et
al: The 5th edition of the World Health Organization Classification
of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic
Neoplasms. Leukemia. 36:1703–1719. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Thota S and Gerds AT: Myelodysplastic and
myeloproliferative neoplasms: Updates on the overlap syndromes.
Leuk Lymphoma. 59:803–812. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Urrechaga E, Boveda O and Aguirre U:
Improvement in detecting sepsis using leukocyte cell population
data (CPD). Clin Chem Lab Med. 57:918–926. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vanderlinde RE: Measurement of total
lactate dehydrogenase activity. Ann Clin Lab Sci. 15:13–31.
1985.PubMed/NCBI
|
|
5
|
Chabot-Richards DS and George TI:
Leukocytosis. Int J Lab Hematol. 36:279–288. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Riley LK and Rupert J: Evaluation of
patients with leukocytosis. Am Fam Physician. 92:1004–1011.
2015.PubMed/NCBI
|
|
7
|
Langabeer SE, Bhreathnach U, Cahill MR,
Elhassadi E, Ní Loingsigh S, Conneally E and Enright H: Can
absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid
leukemia from chronic myelomonocytic leukemia? Blood Cells Mol Dis.
87(102521)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dhakal P, Gundabolu K, Amador C, Rayamajhi
S and Bhatt VR: Atypical chronic myeloid leukemia: A rare entity
with management challenges. Future Oncol. 14:177–185.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thiele J, Kvasnicka HM, Schmitt-Graeff A,
Zirbes TK, Birnbaum F, Kressmann C, Melguizo-Grahmann M,
Frackenpohl H, Sprungmann C, Leder LD, et al: Bone marrow features
and clinical findings in chronic myeloid leukemia-a comparative,
multicenter, immunohistological and morphometric study on 614
patients. Leuk Lymphoma. 36:295–308. 2000.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shekhar R, Srinivasan VK and Pai S: How I
investigate dysgranulopoiesis. Int J Lab Hematol. 43:538–546.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dao KH and Tyner JW: What's different
about atypical CML and chronic neutrophilic leukemia? Hematology Am
Soc Hematol Educ Program. 2015:264–271. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Crisa E, Nicolosi M, Ferri V, Favini C,
Gaidano G and Patriarca A: Atypical chronic myeloid leukemia: Where
are we now? Int J Mol Sci. 21(6862)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Meggendorfer M, Bacher U, Alpermann T,
Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T and
Schnittger S: SETBP1 mutations occur in 9% of MDS/MPN and in 4% of
MPN cases and are strongly associated with atypical CML, monosomy
7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia.
27:1852–1860. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Meggendorfer M, Haferlach T, Alpermann T,
Jeromin S, Haferlach C, Kern W and Schnittger S: Specific molecular
mutation patterns delineate chronic neutrophilic leukemia, atypical
chronic myeloid leukemia, and chronic myelomonocytic leukemia.
Haematologica. 99:e244–e246. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gambacorti-Passerini CB, Donadoni C,
Parmiani A, Pirola A, Redaelli S, Signore G, Piazza V, Malcovati L,
Fontana D, Spinelli R, et al: Recurrent ETNK1 mutations in atypical
chronic myeloid leukemia. Blood. 125:499–503. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Piazza R, Valletta S, Winkelmann N,
Redaelli S, Spinelli R, Pirola A, Antolini L, Mologni L, Donadoni
C, Papaemmanuil E, et al: Recurrent SETBP1 mutations in atypical
chronic myeloid leukemia. Nat Genet. 45:18–24. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Maxson JE, Gotlib J, Pollyea DA,
Fleischman AG, Agarwal A, Eide CA, Bottomly D, Wilmot B, McWeeney
SK, Tognon CE, et al: Oncogenic CSF3R mutations in chronic
neutrophilic leukemia and atypical CML. N Engl J Med.
368:1781–1790. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang SA, Hasserjian RP, Fox PS, Rogers HJ,
Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J,
Kanagal-Shamanna R, et al: Atypical chronic myeloid leukemia is
clinically distinct from unclassifiable
myelodysplastic/myeloproliferative neoplasms. Blood. 123:2645–2651.
2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang H, Wilmot B, Bottomly D, Dao KT,
Stevens E, Eide CA, Khanna V, Rofelty A, Savage S, Reister Schultz
A, et al: Genomic landscape of neutrophilic leukemias of ambiguous
diagnosis. Blood. 134:867–879. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Montalban-Bravo G, Kanagal-Shamanna R,
Sasaki K, Masarova L, Naqvi K, Jabbour E, DiNardo CD, Takahashi K,
Konopleva M, Pemmaraju N, et al: Clinicopathologic correlates and
natural history of atypical chronic myeloid leukemia. Cancer.
127:3113–3124. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Patnaik MM, Barraco D, Lasho TL, Finke CM,
Reichard K, Hoversten KP, Ketterling RP, Gangat N and Tefferi A:
Targeted next generation sequencing and identification of risk
factors in World Health Organization defined atypical chronic
myeloid leukemia. Am J Hematol. 92:542–548. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Soverini S, Abruzzese E, Bocchia M,
Bonifacio M, Galimberti S, Gozzini A, Iurlo A, Luciano L, Pregno P,
Rosti G, et al: Next-generation sequencing for BCR-ABL1 kinase
domain mutation testing in patients with chronic myeloid leukemia:
A position paper. J Hematol Oncol. 12(131)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gotlib J, Maxson JE, George TI and Tyner
JW: The new genetics of chronic neutrophilic leukemia and atypical
CML: Implications for diagnosis and treatment. Blood.
122:1707–1711. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Arber DA, Orazi A, Hasserjian RP, Borowitz
MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S,
et al: International consensus classification of myeloid neoplasms
and acute leukemias: Integrating morphologic, clinical, and genomic
data. Blood. 140:1200–1228. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Monte-Mor Bda C, Ayres-Silva Jde P,
Correia WD, Coelho AC, Solza C, Daumas AH, Bonamino MH, Santos FP,
Datoguia TS, Pereira Wde O, et al: Clinical features of JAK2V617F-
or CALR-mutated essential thrombocythemia and primary
myelofibrosis. Blood Cells Mol Dis. 60:74–77. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cross NCP: Update on CML-Like Disorders.
Clin Lymphoma Myeloma Leuk. 20 (Suppl 1):S101–S102. 2020.PubMed/NCBI View Article : Google Scholar
|
